{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:49:06Z","timestamp":1780890546683,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272277"],"award-info":[{"award-number":["81272277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372810"],"award-info":[{"award-number":["81372810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.pathol.2019.09.014","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T08:04:06Z","timestamp":1577347446000},"page":"206-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"52","author":[{"given":"Hui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoshuai","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.09.014_bib1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2005.04.033","article-title":"Two cases of non-Hodgkin's lymphoma presenting as primary gynecologic malignancies","volume":"98","author":"Kendrick","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pathol.2019.09.014_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1006\/gyno.1996.4583","article-title":"Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy","volume":"64","author":"Dimopoulos","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pathol.2019.09.014_bib3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/modpathol.3880442","article-title":"Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases","volume":"14","author":"Vang","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.014_bib4","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1002\/cncr.30895","article-title":"C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: impact of additional \"hits\" and outcomes with subsequent therapy","volume":"123","author":"Epperla","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2019.09.014_bib5","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1200\/JCO.2016.70.3660","article-title":"Clinical impact of the cell-of-origin classification and the MYC\/BCL2 dual expresser status in diffuse large B-cell lymphoma treated within prospective clinical trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group","volume":"35","author":"Staiger","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.014_bib6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/leu.2015.43","article-title":"Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma","volume":"29","author":"Horn","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.014_bib7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2019.09.014_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2019.09.014_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.pathol.2019.09.014_bib10","first-page":"51","article-title":"Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy","volume":"18","author":"Jardin","year":"2014","journal-title":"Discov Med"},{"key":"10.1016\/j.pathol.2019.09.014_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2019.09.014_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2019.09.014_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2019.09.014_bib14","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.pathol.2019.09.014_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2019.09.014_bib16","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.09.014_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3960\/jslrt.56.71","article-title":"Molecular pathogenesis of diffuse large B-cell lymphoma","volume":"56","author":"Dobashi","year":"2016","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.pathol.2019.09.014_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.prp.2017.12.017","article-title":"Genomic analysis reveals distinct subtypes in two rare cases of primary ovarian lymphoma","volume":"214","author":"Khattar","year":"2018","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.pathol.2019.09.014_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.014_bib20","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1182\/blood-2015-10-676700","article-title":"Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL","volume":"127","author":"Savage","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.014_bib21","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1200\/JCO.2014.60.2383","article-title":"Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies","volume":"33","author":"Scott","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.014_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00000478-199302000-00007","article-title":"Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases","volume":"17","author":"Monterroso","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.014_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.12659\/AJCR.882997","article-title":"Ovary involvement of diffuse large B-cell lymphoma","volume":"13","author":"Hu","year":"2012","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.pathol.2019.09.014_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1471-0528.1988.tb06611.x","article-title":"Malignant lymphoma presenting as an ovarian tumour: a clinicopathological analysis of 34 cases","volume":"95","author":"Fox","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.pathol.2019.09.014_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0090-8258(03)00229-4","article-title":"A\u00a0case of malignant lymphoma of the ovary manifesting like an advanced ovarian cancer","volume":"90","author":"Yamada","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pathol.2019.09.014_bib26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/PAS.0000000000000434","article-title":"Triple-hit B-cell lymphoma with MYC, BCL2, and BCL6 translocations\/rearrangements: clinicopathologic features of 11 cases","volume":"39","author":"Wang","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.014_bib27","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bjh.15653","article-title":"Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"185","author":"Stengel","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.014_bib28","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41379-018-0041-7","article-title":"Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas","volume":"31","author":"Menguy","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.014_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/PAT.0000000000000076","article-title":"Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis","volume":"46","author":"Lynnhtun","year":"2014","journal-title":"Pathology"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T21:02:42Z","timestamp":1579899762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519304301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0031302519304301"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.014","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}